152 related articles for article (PubMed ID: 29955617)
21. Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients.
Sahasrabhojane P; Galloway-Peña J; Velazquez L; Saldaña M; Horstmann N; Tarrand J; Shelburne SA
Int J Antimicrob Agents; 2014 Jun; 43(6):558-62. PubMed ID: 24721231
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditis.
Ercibengoa M; Goenaga MA; Ardanuy C; Grau I; García-de-la-Maria C; Almela M; Miro JM; Navas E; Fariñas MC; de Alegría CR; de la Torre J; Fernández F; Marín M; Muñoz P; Orden B; Oteo JA; García-Álvarez L; de Alarcón A; Jiménez JAL; Marimón JM
BMC Infect Dis; 2019 Mar; 19(1):291. PubMed ID: 30922322
[TBL] [Abstract][Full Text] [Related]
23. Clinical and microbiological profile of Viridans group streptococcal bacteraemia; experience from South India.
Arjun R; Niyas VKM; Hussain F; Surendran S; Mohan V
Infez Med; 2024; 32(1):37-44. PubMed ID: 38456022
[TBL] [Abstract][Full Text] [Related]
24. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
Snyder M; Pasikhova Y; Baluch A
Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
[TBL] [Abstract][Full Text] [Related]
25. Infections caused by viridans streptococci in patients with neutropenia.
Tunkel AR; Sepkowitz KA
Clin Infect Dis; 2002 Jun; 34(11):1524-9. PubMed ID: 12015700
[TBL] [Abstract][Full Text] [Related]
26. Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy.
Kerr KG; Armitage HT; McWhinney PH
Support Care Cancer; 1999 Jan; 7(1):28-30. PubMed ID: 9926971
[TBL] [Abstract][Full Text] [Related]
27. [Classical and new approaches in laboratory diagnosis of viridans streptococci].
Ergin A
Mikrobiyol Bul; 2010 Jul; 44(3):495-503. PubMed ID: 21064001
[TBL] [Abstract][Full Text] [Related]
28. GyrB polymorphisms accurately assign invasive viridans group streptococcal species.
Galloway-Peña J; Sahasrabhojane P; Tarrand J; Han XY; Shelburne SA
J Clin Microbiol; 2014 Aug; 52(8):2905-12. PubMed ID: 24899021
[TBL] [Abstract][Full Text] [Related]
29. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
[TBL] [Abstract][Full Text] [Related]
30. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
[TBL] [Abstract][Full Text] [Related]
31. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
32. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
[TBL] [Abstract][Full Text] [Related]
33. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review.
Danilatou V; Mantadakis E; Galanakis E; Christidou A; Stiakaki E; Kalmanti M
Scand J Infect Dis; 2003; 35(11-12):873-6. PubMed ID: 14723365
[TBL] [Abstract][Full Text] [Related]
34. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
35. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
36. Value of matrix-assisted laser desorption ionization-time of flight for routine identification of viridans group streptococci causing bloodstream infections.
López Roa P; Sánchez Carrillo C; Marín M; Romero F; Cercenado E; Bouza E
Clin Microbiol Infect; 2013 May; 19(5):438-44. PubMed ID: 22510157
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of MALDI-TOF and 16S rRNA methods in identification of viridans group streptococci].
Süzük Yıldız S; Kaşkatepe B; Altınok S; Çetin M; Karagöz A; Savaş S
Mikrobiyol Bul; 2017 Jan; 51(1):1-9. PubMed ID: 28283005
[TBL] [Abstract][Full Text] [Related]
38. Streptococcal bacteremia in neutropenic adult patients.
Devaux Y; Archimbaud E; Guyotat D; Plotton C; Maupas J; Fleurette J; Fiere D
Nouv Rev Fr Hematol (1978); 1992; 34(2):191-5. PubMed ID: 1502026
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of clarithromycin in preventing viridans streptococcal bacteremia following autologous stem cell transplantation.
Naqvi B; Dorsky D; Ali SA; Feingold JM; Edwards RL; Bona RD; Clive J; Tutschka PJ; Bilgrami S
Infection; 2001 Aug; 29(4):201-4. PubMed ID: 11545480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
